# FDA recall D-966-2013

> **Beacon Hill Medical Pharmacy, P.C.** · Class II · drug recall initiated 2013-07-26.

## Product

H.C.G. (COMPOUNDED), 5,000, 8, 000, 10,000, 11,000 and 12,000 UNIT VIALS INJECTABLE, all presentations, FOR INTRAVENO and SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI

## Reason for recall

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

## Distribution

USA nationwide

## Key facts

- **Recall number:** D-966-2013
- **Recalling firm:** Beacon Hill Medical Pharmacy, P.C.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-07-26
- **Report date:** 2013-09-18
- **Termination date:** 2014-07-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Southfield, MI, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-966-2013

## Citation

> AI Analytics. FDA recall D-966-2013. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-966-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*